Duyar, S. S. Et Al. 2015. The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3 , 607-614.

Duyar, S. S., Yilmaz, A., Demirag, F., Erdogan, Y., Yazici, U., & Karakaya, J., (2015). The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3, 607-614.

Duyar, Sezgi Et Al. "The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3, 607-614, 2015

Duyar, Sezgi S. Et Al. "The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3, pp.607-614, 2015

Duyar, S. S. Et Al. (2015) . "The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3, pp.607-614.

@article{article, author={Sezgi Sahin Duyar Et Al. }, title={The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/P504S) as an immunohistochemical marker in malign pleural mesothelioma}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2015, pages={607-614} }